Deal

EQT to acquire Dako

The EQT V funds announced today the purchase of the Danish company Dako Denmark AS, for the enterprise value of DKK 7.250 million.

The current owners are descendants of the founder; the Danish medical doctor Niels Harboe (61%), the Norwegian pharmaceutical company Novo Nordisk (27%) and a group of other minor stakeholders (12%).

Dako Denmark is a world leading company within cancer diagnostics, with more than 40 years of experience in its field. The company is headquartered in Denmark.

The transaction has yet to be approved by competition authorities and shareholders in Dako Denmark.

Read more

 


FundEQT V LP Argentum share 0.82%
Portfolio CompanyDako Denmark
Date of Transaction2007-02-28
TransactionAcquisition
Sellercompany founder Niels Harboe (61%), Novo Nordisk A/S (27%) and others (12%).
BuyerEQT V LP
Size of TransactionDKK 7.3m
Ind. FocusLife Science
GeographyDenmark
StageSmall/mid-cap buyout
 

More deals

(2011-07-13)